Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05732727

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension in Patients With Moderate to Severe Chronic Kidney Disease: an Open Label, Cluster Randomized Controlled Phase 3 Trial

Led by University Hospital, Tours · Updated on 2025-12-01

720

Participants Needed

40

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic kidney disease (CKD) is a serious global health issue often complicated by hypertension, which increases risks for death, heart problems, and kidney failure. Lowering blood pressure is known to reduce these risks, but the best drug strategies for controlling blood pressure in CKD patients remain unclear. Researchers believe that patients with CKD and uncontrolled hypertension may have excess fluid, and that using diuretics as a second treatment after standard drugs may help improve outcomes. This trial compares two approaches for managing uncontrolled hypertension in patients with moderate to severe CKD. One group will follow a specific treatment plan using diuretics to adjust blood pressure medication, while the other group will receive usual care based on their clinician's standard methods. The study is an open-label, cluster randomized controlled Phase 3 trial evaluating these strategies over time. Participants will be monitored for up to 36 months to assess key health outcomes including progression to end-stage kidney disease, decline in kidney function, cardiovascular events, and overall mortality. The trial will also track blood pressure changes, medication use, protein levels in urine, and quality of life. Regular assessments will help researchers understand the impact of diuretic-based treatment compared to usual care in this patient population.

CONDITIONS

Brief Title

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 years or older with a clinical frailty score 65 for those over 80 years
  • Moderate to advanced chronic kidney disease with eGFR between 15 and 44.9 mL/min/1.73m²
  • Arterial hypertension treated with at least one blood pressure lowering drug (ACE inhibitor or ARB) at maximum tolerated dose stable for at least one month
  • Uncontrolled office blood pressure confirmed by home or ambulatory blood pressure monitoring
  • Participant covered by or entitled to social security
  • Written informed consent obtained
Not Eligible

You will not qualify if you...

  • Under any legal protection measures
  • Pregnant or breastfeeding women
  • Women of childbearing potential without highly effective contraception
  • Clinical signs of low blood volume (hypovolemia)
  • Symptomatic orthostatic hypotension
  • Low sodium levels (hyponatremia below 130 mmol/L)
  • Abnormal potassium levels (below 3.5 or above 5.5 mmol/L)
  • Major cardiovascular events in last three months (heart attack, heart failure hospitalization, stroke)
  • Current cancer requiring chemotherapy
  • Solid organ transplant recipients
  • Use of two or more diuretics
  • Use of mineralocorticoid receptor antagonists
  • Polycystic kidney disease treated with Tolvaptan
  • Contraindication to diuretics used in the study
  • Severe heart failure (NYHA class III or IV)
  • Severe liver cirrhosis (Child-Pugh B or C)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 36 months

Participants receive intensified blood pressure lowering therapy either through an antihypertensive algorithm based on diuretics or standard care management to control hypertension.

Regular visits as determined by clinicians for adjustment and monitoring

Trial Site Locations

Total: 40 locations

1

Department of Nephrology, University Hospital of Angers

Angers, France, 49933

Actively Recruiting

2

Department of Nephrology, University Hospital of Bordeaux

Bordeaux, France, 33000

Actively Recruiting

3

AUB Santé foundation, Brest

Brest, France, 29200

Actively Recruiting

4

Department of Nephrology, University Hospital of Brest

Brest, France, 29200

Actively Recruiting

5

Department of Nephrology, Hospital of Chalon-sur-Saône

Chalon-sur-Saône, France

Actively Recruiting

6

Department of Nephrology, Hospital of Chartres

Chartres, France, 28630

Actively Recruiting

7

Department of Nephrology, University Hospital of Clermont-Ferrand

Clermont-Ferrand, France, 63001

Actively Recruiting

8

Department of Nephrology, Hospital of Colmar

Colmar, France, 68024

Actively Recruiting

9

Department of Nephrology, University Hospital of Grenoble

Grenoble, France, 38043

Actively Recruiting

10

Department of Nephrology, Hospital of Haguenau

Haguenau, France, 67500

Actively Recruiting

11

Department of Nephrology, Departemental Hospital of Vendée

La Roche-sur-Yon, France, 85925

Actively Recruiting

12

ECHO Santé Association, Le Mans

Le Mans, France, 72100

Actively Recruiting

13

Department of Nephrology, Hospital of Le Puy en Velay

Le Puy-en-Velay, France, 43012

Actively Recruiting

14

Department of Nephrology, University Hospital of Lille

Lille, France, 59000

Actively Recruiting

15

Department of Nephrology, University Hospital of Limoges

Limoges, France, 87042

Actively Recruiting

16

AUB Santé foundation, Lorient

Lorient, France, 56100

Actively Recruiting

17

Department of Nephrology, University Hospital of Lyon

Lyon, France, 69003

Actively Recruiting

18

Department of Nephrology, University Hospital of Marseille

Marseille, France, 13005

Actively Recruiting

19

Department of Nephrology, Regional Hospital of Metz

Metz, France, 57085

Actively Recruiting

20

Department of Nephrology, Régional Hospital of Mulhouse

Mulhouse, France, 68100

Actively Recruiting

21

Department of Nephrology, University Hospital of Nantes

Nantes, France, 44093

Actively Recruiting

22

ECHO Santé Association, Nantes

Nantes, France, 44402

Actively Recruiting

23

Department of Nephrology, University Hospital of Nîmes

Nîmes, France, 30029

Actively Recruiting

24

Department of Nephrology, Hospital of Orléans

Orléans, France, 45067

Actively Recruiting

25

Department of Nephrology, European Hospital Georges Pompidou, AP-HP

Paris, France, 75015

Active, Not Recruiting

26

Department of Nephrology, Necker Hospital, AP-HP

Paris, France, 75015

Actively Recruiting

27

Department of Nephrology, Bichat Hospital, AP-HP

Paris, France, 75018

Actively Recruiting

28

Department of Nephrology, Tenon Hospital, AP-HP

Paris, France, 75020

Active, Not Recruiting

29

Department of Nephrology, Hospital of Perpignan

Perpignan, France, 66046

Actively Recruiting

30

Department of Nephrology, University Hospital of Reims

Reims, France, 51092

Actively Recruiting

31

Department of Nephrology, University Hospital of Rennes

Rennes, France, 35033

Actively Recruiting

32

Department of Nephrology, Hospital of Roubaix

Roubaix, France, 59100

Actively Recruiting

33

Department of Nephrology, University Hospital of Rouen

Rouen, France, 76230

Actively Recruiting

34

Department of Nephrology, University Hospital of Saint Etienne

Saint-Etienne, France, 42270

Actively Recruiting

35

ECHO Santé Association, Saint Herblain

Saint-Herblain, France, 44819

Active, Not Recruiting

36

Department of Nephrology, Hospital of Saint Malo

St-Malo, France, 35400

Actively Recruiting

37

Department of Nephrology, Hospital of Strasbourg

Strasbourg, France, 67000

Actively Recruiting

38

Department of Nephrology, University Hospital of Tours

Tours, France, 37044

Actively Recruiting

39

Department of Nephrology, Hospital of Valenciennes

Valenciennes, France, 59322

Actively Recruiting

40

Department of Nephrology, University Hospital of Nancy

Vandœuvre-lès-Nancy, France, 54511

Actively Recruiting

Loading map...

Research Team

B

Bénédicte Sautenet, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Biomarker-targeted Clinical Trial to Optimize Treatment fo...

Chronic Kidney Disease(CKD)

Actively Recruiting

4 locations

A Randomized, Double-Blind, Placebo Controlled, Parallel Gro...

Uncontrolled Hypertension

Actively Recruiting

20 locations

A Randomized, Double-blind, Placebo-controlled Study to Eval...

Chronic Kidney Disease(CKD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here